Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine for intraoperative phantom limb syndrome
ChiCTR-IIR-15007626Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in phantom limb syndrome, Perioperative anxiety, perioperative pain and 2 more (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Intraoperative phantom limb syndrome, Anxiety and 12 more. Planned start Mar 2016; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
phantom limb syndromePerioperative anxietyperioperative painNausea and Vomitingpostanesthetic shivering (PAS)
Beyond the preview
Go deeper on ChiCTR-IIR-15007626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-15007626.